Hans Lennart Rudolf Wigzell

CIK 1492766 · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$723.2K

Companies

2

Total Filings

30

Lifetime Open-Market Net

-$11.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRPT Director 42,098 $17.18 $723.2K -$11.03M 25 2026-06-05
Sarepta Therapeutics, Inc. (AVII) Delisted Director 833 $0 2 2011-06-22

Recent Filings · Page 3 of 3

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-03-07 SRPT Grant (A) +3,418 $0 EDGAR
2017-12-04 SRPT Mixed -$323.4K EDGAR
2017-03-14 SRPT Grant (A) +1,000 $0 EDGAR
2016-03-02 SRPT Grant (A) +1,000 $0 EDGAR
2015-03-03 SRPT Grant (A) +1,000 $0 EDGAR
2014-03-04 SRPT Grant (A) +1,000 $0 EDGAR
2013-06-06 SRPT Grant (A) +1,000 $0 EDGAR
2012-08-27 SRPT Grant (A) +833 $0 EDGAR
2011-06-22 Sarepta Therapeutics, Inc. (AVII) Delisted Grant (A) +5,000 $0 EDGAR
2010-06-09 Sarepta Therapeutics, Inc. (AVII) Delisted Grant (A) $0 EDGAR
Showing 2130 of 30
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.